跳至主要内容
临床试验/KCT0008188
KCT0008188招募中未知

Circulating tumor DNA (ctDNA) analyses as a predictive marker for cancer treatment in solid tumors

Chonnam National University Hospital Hwasun Hospital0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
18(Year) 至 90(Year)(—)
性别
All

入选标准

  • Male and female participants >=18 years of age inclusive, at the time of signing the informed consent
  • Histologically confirmed metastatic solid cancer
  • Participants with accessible tumor will undergo a pre-treatment
  • Measurable disease according to Response Evaluation Criteria in Solid Tumors (RECIST) v 1.1 after operation, radiotherapy or chemotherapy
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
  • Agreement to donate blood sample (20ml) during the study period
  • Ability to comply with the study protocol in the investigator's judgement

排除标准

  • Histologically who are not confirmed with solid cancer
  • Amount of sample that can not be analyzed

研究者

发起方
Chonnam National University Hospital Hwasun Hospital

相似试验